J Monjardino

Author PubWeight™ 44.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994 2.00
2 The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles. J Med Virol 1982 1.81
3 Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985 1.45
4 Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985 1.43
5 Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998 1.33
6 Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). Gut 1982 1.28
7 Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993 1.22
8 The mechanism of replication of hepatitis B virus: evidence of asymmetric replication of the two DNA strands. J Med Virol 1984 1.18
9 Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J (Clin Res Ed) 1985 1.02
10 Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA 1998 1.02
11 Cloning and sequencing of the structural region and expression of putative core gene of hepatitis C virus from a British case of chronic sporadic hepatitis. J Gen Virol 1992 0.99
12 Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Gut 1985 0.98
13 Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy. Gut 1983 0.96
14 Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984 0.96
15 Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother 1983 0.96
16 Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA. J Gen Virol 1994 0.95
17 Expression, purification, and partial characterization of HCV RNA polymerase. Biochem Biophys Res Commun 1997 0.94
18 Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 1984 0.93
19 Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice. Gastroenterology 1980 0.91
20 Denaturation of polyoma DNA by phage T4 gene 32 protein. Nature 1975 0.90
21 Characterization of stable hepatitis delta expressing hepatoma cell lines: effect of HDAg on cell growth. Prog Clin Biol Res 1993 0.88
22 Serological response and detection of viraemia in acute hepatitis C virus infection. J Hepatol 1992 0.88
23 Serum HCV RNA levels in chronic HCV hepatitis measured by quantitative PCR assay; correlation with serum AST. J Virol Methods 1994 0.86
24 Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease. J Hepatol 1985 0.86
25 Analysis of hepatitis virus DNA in the liver and serum of HBe antigen positive chimpanzee carriers. J Med Virol 1982 0.85
26 Failure to detect nucleic acid homology between some non-A, non-B viruses and hepatitis B virus DNA. J Med Virol 1983 0.84
27 Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus. J Med Virol 1993 0.83
28 Cloning and expression of an immunodominant region of the hepatitis delta antigen. J Gen Virol 1990 0.82
29 Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside. Gut 1984 0.82
30 An in situ hybridization, molecular biological and immunohistochemical study of hepatitis delta virus in woodchucks. Hepatology 1991 0.82
31 Sequence, expression and reconstitution of an HCV genome from a British isolate derived from a single blood donation. J Viral Hepat 2000 0.81
32 Cloning and analysis of integrated hepatitis B virus DNA of the adr subtype derived from a human primary liver cell carcinoma. J Gen Virol 1986 0.81
33 Acyclovir inhibits hepatitis B virus replication in man. Lancet 1982 0.80
34 Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. Hepatology 1990 0.80
35 Mapping of 5' ends of virion-derived HBV DNA. Virology 1992 0.80
36 Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection. J Med Virol 1992 0.80
37 Hepatitis delta virus and the interferon system. Prog Clin Biol Res 1993 0.80
38 Integration of hepatitis B virus DNA through a mutational hot spot within the cohesive region in a case of hepatocellular carcinoma. J Gen Virol 1992 0.79
39 Extraction and purification of rat alpha-fetoprotein. Biochem Med 1977 0.79
40 Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks. J Gen Virol 1995 0.78
41 Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculoviruses, controls HDV superinfection. Prog Clin Biol Res 1993 0.78
42 Clinical uses of HBV-DNA assays. J Virol Methods 1985 0.77
43 Emergence of the long form of hepatitis delta virus antigen in transfected cells after intrahepatic transfection and during natural infection. Prog Clin Biol Res 1993 0.77
44 Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon. Q J Med 1989 0.76
45 Hepatitis C virus replication in hepatocellular carcinoma. J Clin Pathol 1995 0.75
46 Transmission of HBV by liver allografts. Lancet 1995 0.75
47 Polypeptide profile of HBSAg excreted by a human hepatoma cell line. Virology 1979 0.75
48 Purification of woodchuck hepatitis surface antigen using a monoclonal antibody raised against the antigen. J Virol Methods 2001 0.75
49 Relatedness of non-A, non-B hepatitis viruses. Lancet 1982 0.75
50 In vitro transcription of polyoma DNA. Biochem Biophys Res Commun 1978 0.75
51 Hepatitis delta virus and the host response: current status and future perspectives. Prog Clin Biol Res 1993 0.75
52 Inhibition of hepatitis B viral replication by lymphoblastoid interferon. Philos Trans R Soc Lond B Biol Sci 1982 0.75
53 [Neoplasms of the orbit]. J Soc Cienc Med Lisb 1966 0.75
54 Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver. Histopathology 1992 0.75
55 Hepatitis C virus type I(1a) in northern China. J Med Virol 1995 0.75
56 The molecular relationship between HBV infection and hepatoma in Kenya. East Afr Med J 1985 0.75
57 Prevention and treatment of hepatitis delta virus infection. Prog Clin Biol Res 1991 0.75
58 Base changes at positions 1014 and 578 of delta virus RNA in Greek isolates maintain base pair in rod conformation with efficient RNA editing. J Med Virol 1995 0.75